DK1041896T3 - Fedtblanding - Google Patents

Fedtblanding

Info

Publication number
DK1041896T3
DK1041896T3 DK98966662T DK98966662T DK1041896T3 DK 1041896 T3 DK1041896 T3 DK 1041896T3 DK 98966662 T DK98966662 T DK 98966662T DK 98966662 T DK98966662 T DK 98966662T DK 1041896 T3 DK1041896 T3 DK 1041896T3
Authority
DK
Denmark
Prior art keywords
fatty acids
fat blend
linolenic
gamma
eicosapentaenoic
Prior art date
Application number
DK98966662T
Other languages
Danish (da)
English (en)
Inventor
Guenther Sawatzki
Guenther Boehm
Gerhard Kohn
Sandra Farwer
Michael Kliem
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of DK1041896T3 publication Critical patent/DK1041896T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings, cooking oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Edible Oils And Fats (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fats And Perfumes (AREA)
  • Lubricants (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98966662T 1997-12-23 1998-12-22 Fedtblanding DK1041896T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19757414A DE19757414A1 (de) 1997-12-23 1997-12-23 Fettmischung
PCT/EP1998/008409 WO1999033355A2 (fr) 1997-12-23 1998-12-22 Melange de corps gras

Publications (1)

Publication Number Publication Date
DK1041896T3 true DK1041896T3 (da) 2002-06-17

Family

ID=7853100

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98966662T DK1041896T3 (da) 1997-12-23 1998-12-22 Fedtblanding

Country Status (15)

Country Link
US (1) US7045143B1 (fr)
EP (1) EP1041896B1 (fr)
JP (1) JP2001526908A (fr)
CN (1) CN1091363C (fr)
AT (1) ATE213391T1 (fr)
AU (1) AU758079B2 (fr)
BR (1) BR9814467A (fr)
CA (1) CA2316298C (fr)
DE (2) DE19757414A1 (fr)
DK (1) DK1041896T3 (fr)
ES (1) ES2173673T3 (fr)
HK (1) HK1033541A1 (fr)
NO (1) NO316302B1 (fr)
NZ (1) NZ505608A (fr)
WO (1) WO1999033355A2 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19757414A1 (de) 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
DE19914104A1 (de) * 1999-03-23 2000-09-28 Siegfried Seifert Verfahren zur Verbesserung der körperlichen Erscheinung eines Menschen unter Verabreichung einer Fett-Eiweiß-Diät
US6340705B1 (en) * 1999-09-10 2002-01-22 Monsanto Technology, Llc Use of α-linolenic acid metabolites for treatment or prevention of cancer
WO2001024812A1 (fr) * 1999-10-06 2001-04-12 N.V. Nutricia UTILISATION DU FACTEUR DE CROISSANCE TRANSFORMANT β ET DE FACTEURS DE CROISSANCE POUR LE TRAITEMENT ET LA PREVENTION D'UNE MALADIE DE LA MUQUEUSE INTESTINALE
GB0016045D0 (en) 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
US6667064B2 (en) * 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
CA2689808A1 (fr) * 2001-05-14 2002-11-21 Martek Biosciences Corporation Production et utilisation d'une fraction polaire riche en lipides contenant l'acide stearidonique et l'acide gamma-linolenique extraits de graines et de microorganismes
WO2002092779A2 (fr) * 2001-05-17 2002-11-21 Pilot Therapeutics, Inc. Procede d'enrichissement de tissus dans des acides gras polyinsatures a chaine longue
US7163960B2 (en) 2002-03-08 2007-01-16 Monsanto Technology L.L.C. Treatment and prevention of inflammatory disorders
DE10254584A1 (de) * 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
DE10361667A1 (de) * 2003-12-30 2005-07-28 Omega For Life Gmbh Neuartige Fettpulver
EP1723951A1 (fr) * 2005-04-21 2006-11-22 N.V. Nutricia Supplément nutritionnel avec des oligosaccharides pour une catégorie de patients avec HIV
US20080108548A1 (en) * 2004-11-12 2008-05-08 N.V. Nutricia Food Composition For Rapidly Attenuating Inflammatory Responses
US7893106B2 (en) * 2004-11-19 2011-02-22 Martek Biosciences, Corporation Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same
US20090318394A1 (en) * 2004-11-19 2009-12-24 Julie Nauroth Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same
US7884131B2 (en) 2004-11-19 2011-02-08 Martek Biosciences, Corporation Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
WO2007063143A1 (fr) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Melange de lipides utilise pour preparer un produit destine a l'administration enterale ou orale
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
WO2007090162A2 (fr) * 2006-01-31 2007-08-09 Martek Biosciences Corporation OXYLIPINES D'ACIDE STÉARIDONIQUE ET D'ACIDEγ-LINOLÉNIQUE ET PROCÉDÉS DE FABRICATION ET D'UTILISATION
CN101466270A (zh) * 2006-04-11 2009-06-24 马泰克生物科学公司 包含长链多不饱和脂肪酸的食品及其制备方法
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
US20080089981A1 (en) * 2006-10-17 2008-04-17 N.V. Nutricia Ketogenic diet
CA2567879C (fr) * 2006-11-14 2013-03-26 Thomas Greither Compositions d'huile alimentaire nutritive et methodes pour les produire
GB2444896B (en) * 2006-12-18 2010-05-19 Nutraceuticals Ltd Compositions comprising polyunsaturated fatty acids
CN101663031A (zh) * 2007-02-20 2010-03-03 马泰克生物科学公司 来自长链多不饱和脂肪酸的氧脂素及其制备方法和使用方法
CA2688293A1 (fr) * 2007-05-25 2008-12-04 Childrens's Medical Center Corporation Formulations de regime et procedes de traitement d'une inflammation et d'autres troubles
CN101820754A (zh) * 2007-10-04 2010-09-01 雀巢产品技术援助有限公司 用于增强认知功能的组合物与方法
EP2230944B1 (fr) * 2007-11-29 2017-01-04 Monsanto Technology, LLC Produits carnés dont les niveaux d'acides gras bénéfiques ont été augmentés
WO2009086281A1 (fr) * 2007-12-21 2009-07-09 Martek Biosciences Corporation Procédé de préparation d'oxylipines
US20100266746A1 (en) * 2009-04-16 2010-10-21 Monsanto Technology Llc Spread formulations including stearidonic acid
CN102469826A (zh) * 2009-07-15 2012-05-23 索莱有限责任公司 富含ω-3脂肪酸的汤和调味料
IN2012DN02228A (fr) * 2009-09-30 2015-08-21 Solae Llc
WO2011071365A1 (fr) * 2009-12-07 2011-06-16 N.V. Nutricia Composition lipidique équilibrée et son utilisation dans une composition nutritionnelle liquide adaptée à l'alimentation entérale
WO2011091019A1 (fr) * 2010-01-19 2011-07-28 University Of Tennessee Research Foundation Procédés et compositions pour traiter et prévenir une maladie hépatique associée à la nutrition parentérale
US8372465B2 (en) * 2010-02-17 2013-02-12 Bunge Oils, Inc. Oil compositions of stearidonic acid
CA2820960A1 (fr) 2010-12-29 2012-07-05 Abbott Laboratories Produits nutritionnels contenant un nouveau systeme lipidique contenant des monoglycerides
US20120252888A1 (en) 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
WO2012138212A1 (fr) 2011-04-06 2012-10-11 N.V. Nutricia Composition alimentaire pour une alimentation par tube intra-opératoire
US8728546B1 (en) 2013-03-15 2014-05-20 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer, cardiovascular diseases and inflammation
US20150157048A1 (en) * 2013-12-11 2015-06-11 Mead Johnson Nutrition Company Nutritional compositions containing stearidonic acid and uses thereof
US11419350B2 (en) 2016-07-01 2022-08-23 Corbion Biotech, Inc. Feed ingredients comprising lysed microbial cells
CN109527123A (zh) * 2018-12-14 2019-03-29 大连大学 一种对慢性肠炎具有改善作用的调和油
CN112891304B (zh) * 2020-10-14 2022-06-10 麦孚营养科技有限公司 一种高能量密度的脂肪乳剂及其制备方法和其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3924607A1 (de) * 1989-07-21 1991-01-24 Singer Peter Dr Sc Med Diaetetisches nahrungs- oder genussmittel
DE69004081T2 (de) * 1990-05-23 1994-02-10 Nestle Sa Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen.
GB9026648D0 (en) * 1990-12-07 1991-01-23 Efamol Holdings Nutrition
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
AU683027B2 (en) * 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
CA2119000A1 (fr) * 1993-03-19 1994-09-20 David Frederick Horrobin Formulation pour fumeurs
US5714472A (en) * 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
GB9506837D0 (en) * 1995-04-03 1995-05-24 Scotia Holdings Plc Triglycerides
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
ES2463815T3 (es) * 1996-03-26 2014-05-29 Dsm Ip Assets B.V. Agregado tardío de pufa en el transcurso del proceso de preparación de una leche maternizada
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
ATE221324T1 (de) * 1996-11-20 2002-08-15 Nutricia Nv Fette enthaltende ernährungszusammensetzung zur behandlung des stoffwechselssyndroms
DE19757414A1 (de) 1997-12-23 1999-07-01 Nutricia Nv Fettmischung

Also Published As

Publication number Publication date
CA2316298A1 (fr) 1999-07-08
CA2316298C (fr) 2008-11-18
EP1041896A2 (fr) 2000-10-11
JP2001526908A (ja) 2001-12-25
DE59803153D1 (de) 2002-03-28
ES2173673T3 (es) 2002-10-16
NO20003265D0 (no) 2000-06-22
AU2416299A (en) 1999-07-19
AU758079B2 (en) 2003-03-13
WO1999033355A2 (fr) 1999-07-08
ATE213391T1 (de) 2002-03-15
CN1091363C (zh) 2002-09-25
BR9814467A (pt) 2000-10-10
NO316302B1 (no) 2004-01-12
NZ505608A (en) 2002-12-20
CN1282223A (zh) 2001-01-31
DE19757414A1 (de) 1999-07-01
US7045143B1 (en) 2006-05-16
HK1033541A1 (en) 2001-09-07
EP1041896B1 (fr) 2002-02-20
WO1999033355A3 (fr) 1999-09-16
NO20003265L (no) 2000-06-22

Similar Documents

Publication Publication Date Title
DK1041896T3 (da) Fedtblanding
DK1121115T4 (da) PUFA-tilskud
DiGiacomo et al. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study
Nordström et al. Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed
EP1296670B1 (fr) Combinaisons therapeutiques d'acides gras
SG64864A1 (en) Phospholipids
EP0815735A3 (fr) Produit laitier diététiquement équilibré
KR940018091A (ko) 불포화 지방산을 포함하는 처방
JPH08500332A (ja) 炎症性疾患の治療のための非経口的に投与される医薬を調製するためのエマルジョンの使用
DK563388A (da) Isoton omega-3-fedtsyreholdig fedtemulsion og fremgangsmaaden til fremstilling deraf
WO2008147562A3 (fr) Formulations de régime et procédés de traitement d'une inflammation et d'autres troubles
JPH0716076A (ja) 喫煙者のための調製物
IT8423086A1 (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
CN103002889A (zh) Sn-2-单酰基甘油和脂质吸收不良
Peck Essential fatty acid deficiency in renal failure: can supplements really help?
AU1489688A (en) Omega-3 fatty acids in traumatic injury treatment
Darlington Do diets rich in polyunsaturated fatty acids affect disease activity in rheumatoid arthritis?
JP2537645B2 (ja) 薬剤的活性を有する栄養組成物
Ling et al. Early development of essential fatty acid deficiency in rats: fat-free vs. hydrogenated coconut oil diet
CA1334002C (fr) Compositions a base d'acides gras essentiels et methodes de modulation de la concentration des prostaglandines chez les mammiferes
Tamargo et al. Pharmacokinetics and safety profile of omega-3 polyunsaturated fatty acids
Maki et al. Bioavailability of eicosapentaenoic and docosahexaenoic n‐3 polyunsaturated fatty acids in salmon patties compared with capsules
Olafsson et al. Dietary cod liver oil decreases arachidonic acid in rat gastric mucosa and increases stress-induced gastric erosions
Llor et al. The effect of olive oil on inflammatory bowel disease.
Houston The Use of Fish Oil Supplements in Clinical Practice: A Review